Zymeworks Inc. Common Stock Earnings

The next earnings date for Zymeworks Inc. Common Stock has not yet been scheduled.

Analyst Estimates of Zymeworks Inc. Common Stock Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Zymeworks Inc. Common Stock Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	After Market	$0.03	106.52%
04/30/2025	After Market	$-0.30	58.92%
03/04/2025	Before Market	$-0.31	-236.23%
10/31/2024	After Market	$-0.39	2.50%
08/01/2024	After Market	$-0.27	15.63%
05/02/2024	After Market	$-0.42	-44.83%
03/06/2024	After Market	$-0.20	53.49%
11/07/2023	After Market	$-0.41	12.77%
08/10/2023	After Market	$-0.76	-61.70%
05/08/2023	After Market	$-0.36	33.33%
03/07/2023	After Market	$4.65	-3.93%
11/08/2022	After Market	$-0.72	21.74%
08/04/2022	After Market	$-0.97	-1.04%
05/04/2022	After Market	$-1.03	38.32%
02/24/2022	After Market	$-0.76	33.33%
11/03/2021	After Market	$-1.17	0.00%
08/04/2021	After Market	$-1.31	-24.76%
05/05/2021	After Market	$-0.87	15.53%
02/24/2021	After Market	$-0.74	39.34%
11/03/2020	After Market	$-1.43	-57.14%
08/05/2020	After Market	$-0.77	10.47%
05/07/2020	After Market	$-0.64	40.19%
03/02/2020	After Market	$-1.66	-93.02%
11/05/2019	After Market	$-0.70	7.89%
08/02/2019	After Market	$-0.86	-30.30%
05/02/2019	After Market	$-0.43	20.37%
03/06/2019	After Market	$0.29	190.00%
11/06/2018	After Market	$-0.59	11.94%
08/01/2018	Before Market	$-0.22	62.07%
05/01/2018	After Market	$-0.83	-22.06%
03/14/2018	After Market	$-0.68	-6,700.00%
11/08/2017	After Market	$-0.64	-18.52%
08/08/2017	After Market	$-0.38	35.59%
05/16/2017	After Market	$-0.64	-8.47%
03/01/2017	---	$-0.36	---

More About Zymeworks Inc. Common Stock

Website

https://www.zymeworks.com

Country

USA

Full Time Employees

273

Zymeworks Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID). Its therapeutic platforms and fully integrated drug development engine provides the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies that enable the selective modulation of recruited cytotoxic immune cells for various therapeutic applications; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead product candidate consists of zanidatamab, a novel bispecific antibody that targets human epidermal growth factor receptor 2 HER2 that is in Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials; and zanidatamab zovodotin, a HER2 -targeted antibody-drug conjugate that is in Phase 2 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. In addition, the company develops a pipeline of preclinical product candidates. It has strategic partnerships and collaborations with BeiGene, Ltd.; Celgene Corporation; Celgene Alpine Investment Co. LLC; GlaxoSmithKline Intellectual Property Development Limited; Daiichi Sankyo Co., Ltd.; Iconic Therapeutics, Inc.; Merck Sharp & Dohme Research GmbH; and Atreca, Inc. Zymeworks Inc. was incorporated in 2003 and is based in Middletown, Delaware.

“Zymeworks Inc. Common Stock Earnings” Can Refer to the Zymeworks Inc. Common Stock Earnings Date

Some people say “Zymeworks Inc. Common Stock earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Zymeworks Inc. Common Stock position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Zymeworks Inc. Common Stock Stock on the Earnings Date

If you own Zymeworks Inc. Common Stock stock (ZYME) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Zymeworks Inc. Common Stock might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Zymeworks Inc. Common Stock shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Zymeworks Inc. Common Stock Earnings

You can contact us any time if you would like to ask questions about Zymeworks Inc. Common Stock earnings or anything else related to the stock market.